| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $53.1M | -8.2% | +10.7% |
| SG&A Expense | $18.7M | -29.1% | +4.0% |
| Operating Income | -$71.9M | +14.7% | -8.9% |
| Interest Expense | $1.5M | -1.5% | +1.1% |
| Pre-tax Income | -$71.2M | — | -8.3% |
| Income Tax | -$311K | — | -154.1% |
| Net Income | -$70.9M | +14.6% | -6.9% |
| EPS (Basic) | -$0.77 | +14.4% | +2.5% |
| EPS (Diluted) | -$0.77 | +14.4% | +2.5% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $123.0M | +20.2% | -28.6% |
| Short-term Investments | $146.2M | -34.0% | -59.9% |
| Current Assets | $280.4M | -16.0% | -48.8% |
| Total Assets | $333.6M | -14.3% | -44.7% |
| Current Liabilities | $50.1M | -5.3% | +4.6% |
| Long-term Debt | $47.6M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$224.2M | — | — |
| Investing Cash Flow | $224.3M | — | — |
| Financing Cash Flow | $10.6M | — | — |
| +3.6% |
| Total Liabilities | $123.1M | -2.4% | +1.5% |
| Stockholders' Equity | $210.5M | -20.0% | -56.4% |